Previous 10 | Next 10 |
IceCure Medical (ICCM -11.1%) trades 10% higher premarket on announcing the closing of its underwritten public offering of 3.89M shares of the Co.'s ordinary shares, inclusive of 0.58M shares offered pursuant to the underwriters' over-allotment option, at a price to the public ...
Galera Therapeutics (NASDAQ:GRTX) +138% announces primary endpoint met statistical significance in corrected topline efficacy data of phase 3 ROMAN trial of avasopasem. Nuverra Environmental Solutions (NYSE:NES) +33%. Terminix Global Holdings (NYSE:TMX) +25%. MIND Technology (NASDAQ:MIND...
IceCure Medical Ltd. Closes $17 Million Underwritten Public Offering and Partial Exercise of Over-Allotment Option PR Newswire CAESAREA, Israel , Dec. 13, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (the " Company " or " IceCur...
Gainers: Inspira Technologies (NASDAQ:IINN) +92%. Ensysce Biosciences (NASDAQ:ENSC) +79%. Insignia (NASDAQ:ISIG) +44%. Hovnanian Enterprises (NASDAQ:HOVNP) +33%. American Virtual Cloud Technologies (NASDAQ:AVCT) +31%. Blue Star Foods Corp. (NASDAQ:BSFC) +16%. Hovnanian (NYSE:HO...
Gainers: Inspira Technologies (NASDAQ:IINN) +103%, Ensysce Biosciences (NASDAQ:ENSC) +53%, Jasper Therapeutics (NASDAQ:JSPR) +24%, Ambrx Biopharma (NYSE:AMAM) +17%, iSpecimen (NASDAQ:ISPC) +15%. Losers: Reata Pharmaceuticals (NASDAQ:RETA)...
IceCure Medical (NASDAQ:ICCM) priced an underwritten public offering of 3.31M shares at $3.45/share, pre-funded warrants to purchase up to 1.03M ordinary shares at $3.449/pre-funded warrant. This represents the per share public offering price for the ordinary shares less the $0.001/share exer...
IceCure Medical Ltd. Announces Pricing of $15 Million Underwritten Public Offering PR Newswire CAESAREA, Israel , Dec. 9, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (the " Company " or " IceCure "), developer of minimally-in...
IceCure Medical's Interim Results of the ICE3 Clinical Trial for Early-Stage Breast Cancer Cryoablation featured at the 2021 Annual Meeting of the Radiological Society of North America PR Newswire CAESAREA, Israel , Dec. 2, 2021 /PRNewswire/ -- IceCure Medi...
Applied UV (NASDAQ:AUVI) +47%. Skylight Health Group (NASDAQ:SLHG) +27%. Ardelyx (NASDAQ:ARDX) +18%. IceCure Medical (NASDAQ:ICCM) +17%. Energy Focus (NASDAQ:EFOI) +17%. Ambarella (NASDAQ:AMBA) +15% on Q3 results VBI Vaccines (NASDAQ:VBIV) +14% wins FDA approval for Hepatitis B vacc...
IceCure Medical Announces Appointment of Merav Nir Dotan to Vice President Human Resources New executive appointment made commensurate with IceCure's growth related to the increased adoption of its flagship ProSense® Cryoablation System and development of next-generation of...
News, Short Squeeze, Breakout and More Instantly...
99.74% Recurrence Free Rate for Women with Breast Cancer Treated with IceCure's ProSense® Cryoablation System: Key Findings Delivered at 32nd Annual Meeting of the Japanese Breast Cancer Society PR Newswire Demand for minimally invasive breast cancer treatment was ove...
European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment for Metastatic and Recurrent Breast Cancer European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment fo...
U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes PR Newswire CAESAREA, Israel , July 1, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medic...